Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Brousseau

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2023
Summary of the National Advisory Committee on Immunization (NACI) Rapid Response-Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in CanadaApril Killikelly, Nicholas Brousseau
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 17, 2025
Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in InfantsApril Killikelly, Winnie Siu, Nicholas Brousseau
Human Vaccines & Immunotherapeutics|February 8, 2024
Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort studyMelina Thibault, Geneviève Deceuninck, Caroline Quach, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 5, 2025
Summary of the National Advisory Committee on Immunization (NACI) statement on the prevention of respiratory syncytial virus (RSV) in older adultsApril Killikelly, Winnie Siu, Elissa M Abrams, et al.
Vaccine|January 16, 2026
Are hemagglutinin-only influenza vaccines as effective as conventional influenza vaccines against severe infection?Philippe De Wals, Jesse Papenburg, Rodica Gilca, et al.
Vaccine|December 22, 2023
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periodsErnest Lo, Nicholas Brousseau, Fannie Defay, et al.
Human Vaccines & Immunotherapeutics|November 17, 2025
Impact of a multicomponent intervention on maternal Tdap vaccination coverage during a major pertussis resurgence in the province of Quebec, Canada: A quasi-experimental studyPatrick Gauthier Kamgang, Marie-Ève Beauregard, Zhou Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Reply to MusherNicholas Brousseau, Mary P E Slack, Pauline Waight, et al.
Vaccine|June 4, 2026
2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, CanadaSara Carazo, Danuta M Skowronski, Chantal Sauvageau, et al.
Journal of Medical Case Reports|April 18, 2017
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case reportNicholas Brousseau, Donald G Murphy, Vladimir Gilca, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|July 10, 2023
Summary of the National Advisory Committee on Immunization (NACI) Rapid Response-Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in CanadaApril Killikelly, Nicholas Brousseau
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|April 17, 2025
Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in InfantsApril Killikelly, Winnie Siu, Nicholas Brousseau
Human Vaccines & Immunotherapeutics|February 8, 2024
Antenatal tetanus, diphtheria, and acellular pertussis (Tdap) immunization and risk of serogroup 19 IPD in children: An indirect cohort studyMelina Thibault, Geneviève Deceuninck, Caroline Quach, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|September 5, 2025
Summary of the National Advisory Committee on Immunization (NACI) statement on the prevention of respiratory syncytial virus (RSV) in older adultsApril Killikelly, Winnie Siu, Elissa M Abrams, et al.
Vaccine|January 16, 2026
Are hemagglutinin-only influenza vaccines as effective as conventional influenza vaccines against severe infection?Philippe De Wals, Jesse Papenburg, Rodica Gilca, et al.
Vaccine|December 22, 2023
Neighborhood-level vaccine impact on COVID-19 infection and hospital admission in Quebec, Canada, during the Delta and early Omicron periodsErnest Lo, Nicholas Brousseau, Fannie Defay, et al.
Human Vaccines & Immunotherapeutics|November 17, 2025
Impact of a multicomponent intervention on maternal Tdap vaccination coverage during a major pertussis resurgence in the province of Quebec, Canada: A quasi-experimental studyPatrick Gauthier Kamgang, Marie-Ève Beauregard, Zhou Zhou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Reply to MusherNicholas Brousseau, Mary P E Slack, Pauline Waight, et al.
Vaccine|June 4, 2026
2024/25 end-of-season KP.2 vaccine effectiveness against COVID-19 hospitalization in older adults: a test-negative study in Quebec, CanadaSara Carazo, Danuta M Skowronski, Chantal Sauvageau, et al.
Journal of Medical Case Reports|April 18, 2017
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case reportNicholas Brousseau, Donald G Murphy, Vladimir Gilca, et al.
Pageof 6